Russian Researchers Assess the Power of T-Cell Immune Response to Omicron BA.1 and BA.2
Scholars from HSE University and the RAS Institute of Bioorganic Chemistry have demonstrated the efficiency of T-cell immune response against the Omicron variant of SARS-CoV-2. In approximately 90% of vaccinated Europeans, T-cell immunity was as effective against Omicron as with other variants. The results of the study were published in PeerJ.
The Omicron variant of SARS-CoV-2 caused a new wave of the global pandemic. The new mutations help the virus spread more effectively and avoid antibodies, which is why those who have already had the disease or who have been vaccinated are getting infected more often. At the same time, recent data shows that the severity of the disease in vaccinated patients is significantly lower than in people who have not contacted the virus.
The researchers assume that this can be explained by several factors. First, the Omicron variant is slower at infecting the human cells; second, there is a hypothesis that a lighter course of the disease is related to effective action of T-cell immunity.
To confirm this assumption, a team of researchers from the HSE Faculty of Biology and Biotechnology and the RAS Institute of Bioorganic Chemistry (Stepan Nersisyan, Anton Zhiyanov, Alexey Galatenko, Maxim Shkurnikov, Maria Zakharova, Irina Ishina, Inna Kurbatskaia, Azad Mamedov, Alexander Gabibov, and Alexander Tonevitsky) studied the Omicron variant for mutations that help it avoid the T-cell immune response.
The development of T-cell response starts from the recognition of virus peptides (short fragments of proteins) with the molecules of the human major histocompatibility complex (HLA). The more peptides that are recognised, the faster and more efficient T-cell immunity is. Virus mutations can change such peptides, which is why they can stop being recognised by HLA molecules, and the T-cell response will be less effective.
T-CoV, a bioinformatics algorithm, demonstrated that the Omicron variant avoided none of the HLA molecule variants. But it detected several HLA molecule variants that started to become less effective at recognizing the Omicron’s S-protein. An outstanding discovery was the HLA-DRB1*03:01 variant of the molecule. The most important peptide of the virus managed to avoid it. Interestingly, both types of Omicron, BA.1 and BA.2 (also known as ‘Stealth’), evaded immune response recognition, though this was achieved by completely different mutations.
The bioinformatics calculations were verified experimentally in a laboratory. The researchers proved that there is no binding between Omicron peptides and HLA-DRB1*03:01 molecule, which was expressed in vitro.
The researchers emphasise that the initial peptide from the Wuhan basic variant, as well as Delta peptide, are recognised effectively by this molecule.
The authors say that the detected HLA-DRB1*03:01 variant is present in a big share of the global population: for example, in 8.9% of Europeans.
‘The population diversity of HLA molecules, as well as the specificity of their work do not let the virus avoid the T-cell immune response. But the virus has managed to hide its S-protein from one of the HLA molecules. Importantly, most of COVID-19 vaccines (Sputnik V, Pfizer, Moderna, AstraZeneca and some others) carry specifically this virus protein. This means that people with the variant HLA-DRB1*03:01 (who make up 9% of Europe’s population, for example) vaccinated by S-protein may suffer from a more severe course of the disease caused by the Omicron variant.’
Aleksey V. Galatenko
Head, Laboratory of Molecular Physiology
Anton Zhiyanov
Lecturer, Joint Department with RAS Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry
Stepan Nersisyan
Visiting Lecturer, Faculty of Biology and Biotechnology
Alexander Tonevitsky
Dean, Faculty of Biology and Biotechnology
Maxim Shkurnikov
Deputy Dean, Faculty of Biology and Biotechnology
See also:
Paper by HSE Biologists Included in the Top 5 Popular Articles of PeerJ Journal
An article by researchers from HSE University’s Faculty of Biology and Biotechnology is among the most read articles published in the PeerJ journal in 2023. In the paper, the researchers establish a link between the genetic characteristics of the human immune system and its ability to effectively resist new waves of COVID-19. PeerJ is a peer-reviewed open access scientific journal covering research in the field of biological and medical sciences. Every year the editors compile a ranking of the most popular scientific papers.
HSE Researchers Find Out How to Communicate Health Information More Effectively to Fight COVID-19
Focusing on mortality from the COVID-19 virus is no more effective than calls to wear masks and save lives, but it significantly increases people's anxiety. After conducting an experiment with over 15,000 respondents from 84 countries, an international group of researchers, including scientists from HSE, came to this conclusion. The results of the study have been published in the Affective Science journal.
COVID-19 Mortality Highest in More Affluent Russian Regions
COVID-19 came as an unexpected challenge for humanity. Countries adopted different, sometimes diametrically opposed approaches to minimising the pandemic's impact: from hard lockdowns to no restrictions at all, as in Sweden. It was only last week that China began to relax its zero-tolerance policy. Researchers of the HSE Faculty of Economic Sciences have identified a few factors which tend to have the greatest impact on the spread of COVID-19—in Russia, such factors include ambient humidity and temperatures, population mobility, the share of internal migrants in the local population, and household incomes. The study findings are published in Population and Economics.
Acceptance of Vaccination Associated with Lower Social Media Use and Higher Trust in Government
Vaccination is generally considered an essential tool for curbing the COVID-19 pandemic. Although Russia was one of the first countries to develop a vaccine against COVID-19 and launched an immunisation campaign in 2021, its vaccination rates remained low for a long time. By October 2021, only 36% of Russian adults were vaccinated, many of whom were compelled by their employers to do so. Having examined the factors contributing to low trust in vaccination among Russians, HSE economists suggest measures to improve vaccination uptake. The paper is published in Vaccine.
Russian Researchers Assessed the Likelihood of Sleep Disorders after COVID-19
A team of researchers from the HSE Centre for Cognition and Decision Making and the Central State Medical Academy conducted a study on sleep disorders, mood and fatigue after COVID-19. These factors are interrelated and the researchers recommend a comprehensive approach to treat the problem effectively. The work was published in the journal Neuroscience and Behavioral Psychology.
HSE Biologists Prepare Strategy for Universal COVID Test
Russian researchers have developed a strategy to create a cheap and rapid COVID-19 test based on isothermal amplification. According to their publication in Applied Biochemistry and Microbiology, use of this strategy will make it possible to create universal test systems for any of the COVID-19 variants.